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During tumor progression, epithelial cells lose polarity and organized tissue structure. However, it is debated whether this lost epithelial integrity contributes to or is just a consequence of human cancer progression. Few cancer-relevant molecular pathways have been linked to the loss of integrity in mammals so far (1) . Lkb1 is a tumor suppressor protein that also helps to establish polarity and epithelial architecture (1, 2) . We found a mechanism by which loss of Lkb1 gene function damages epithelial integrity to pave the way for progression of tumors.
Lkb1 gene mutations cause PeutzJeghers syndrome, which puts patients at increased cancer risk, and the gene is also found inactivated in several types of common epithelial cancers. The Lkb1 gene is a human equivalent of the Drosophila Par-4 gene, which has a wellestablished role in regulation of epithelial cell polarity. In the current study, we establish that deletion of the Lkb1 gene in the mouse mammary gland damages the integrity of cell-cell junctions and basement membrane (BM) structural fibers underlying the epithelium. This leads to major morphological alterations in the glandular structures. In this system, it appears that most damage is caused by the protein-digesting enzyme known as the serine protease Hepsin. Deletion of the Lkb1 gene compromises the integrity of desmosomes, structures involved in cellto-cell adhesion, where Hepsin is normally localized (Fig. P1 ). Damage to desmosomes thus liberates Hepsin into the fluid inside cells, known as the cytosol. This mislocalized Hepsin is a major player in BM degradation (Fig. P1) .
Surprisingly, however, we find that these Lkb1-dependent damages are not sufficient by themselves to trigger tumor growth in the mouse mammary gland. Why is that? The cell junctions and BM, which require Lkb1 for maintenance, normally keep epithelial cells tightly bound to each other and enable them to organize into specific structures, such as sheets that line cavities and surfaces in the body. All epithelial structures need to restrict the proliferation of constituent cells to maintain structural form and function. The signal for cell proliferation restriction comes from the carefully aligned contacts between neighboring cells and from their contacts with BM. We postulate that although inactivation of Lkb1 removes a large part of the contactdependent inhibition signal, this alone is not sufficient to activate cell cycle machinery in resting differentiated epithelial cells. For tumors to arise, a second hit may be needed to break the cell intrinsic proliferation control mechanisms.
To test the hypothesis, we generated a mouse model with both Lkb1 deletion and c-Myc overexpression in the mammary gland. A cancer-associated gene, or oncogene, known as c-Myc can efficiently push resting cells to the cell cycle. We find that loss of Lkb1 dramatically accelerates tumorigenesis that has been induced by c-Myc. Analysis of the tumor suggests a mechanism for this joint effect on cancer progression: c-Myc induces excess proliferation of the epithelial cells, whereas Lkb1 promotes tumor formation by releasing the cells from the normal structural boundaries imposed by the BM.
Hepsin is likely a major culprit in mediating loss of tumor epithelial integrity. This was supported by the finding that removal of Hepsin in the cancerous organoid epithelial cultures prepared from Myc + ;Lkb1-mice protected epithelial integrity. We also asked whether deletion of Lkb1 is associated with deregulation of Hepsin in human breast cancer. We found that Lkb1 protein was indeed missing in about one-fourth of studied human breast cancer samples; moreover, we found that the cancer samples without Lkb1 frequently overexpressed Hepsin. Therefore, loss of Lkb1 may also turn on Hepsin in human breast cancer.
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